antibody in coeliac disease has been confirmed by Alp and Wright (1971) and by Von Essen, Savilahti, and Pelkonen (1972) . Alp and Wright (1971) also detected the antibody in a proportion of patients with Crohn's disease and occasionally in patients with other diseases.
The significance of this antibody is, therefore, uncertain. It is possible, however, that its presence could be a useful test for gluten-sensitive enteropathy as occurs in patients with dermatitis herpetiformis and coeliac disease, and to investigate this possibility we have compared the incidence of the antibody in these conditions and in other gastrointestinal, haematological, skin, and immunological disorders.
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Patients and Methods

PATIENTS
Sera from the following groups of patients were studied.
Adult coeliac diseaRe One hundred and one patients, of whom 50 were taking a gluten-free diet and 51 a normal diet.
Childhood coeliac disease Forty-six patients, of whom 20 were taking a glutenfree diet and 26 were receiving gluten.
Dermatitis herpetiformis Fifty patients, of whom 20 were taking a gluten-free diet and 30 a normal diet.
In addition, patients with the following gastrointestinal disordeis were studied: other malabsorption states 35; Crohn's disease 38; ulcerative colitis 11; tropical sprue 52; children with a variable degree of jejunal villous atrophy, thought not to be gluten induced (eg, after gastroenteritis malabsorption) 13; alpha-chain disease 4.
Patients with the following skin disorders were also studied: pemphigus 14; pemphigoid 15; vitiligo 15; psoriasis 20; cutaneous vasculitis 8; other skin disorders (including erythema nodosum, erythema multiforme, eczema, photosensitivity, drug eruptions, urticaria, necrobiosis lipoidica, and lichen sclerosis) 36.
The following haematological disorders were studied: adult pernicious anaemia 40; nutritional megaloblastic anaemia 10; autoimmune haemolytic anaemia 25; myelosclerosis 5; chronic lymphocytic leukaemia 9.
Patients with the following conditions in which immune disturbances may occur were also studied: sarcoidosis 12; pregnancy 17; systemic lupus erythematosus 7; alopecia areata 4; myaesthenia gravis 4; thyrotoxicosis 1; scleroderma 6; rheumatoid arthritis 15; fibrosing alveolitis 1; lipodystrophy 1.
Finally, a miscellaneous group of seven patients was studied suffering from rickets 2; reticulum cell sarcoma 1; tuberculosis 1; peptic ulcer 1; leg ulcer 1; Parkinson's disease 1.
METHODS
Sera from all patients were stored at -20C until tested. The presence of antireticulin antibody was detected by indirect immunofluorescence as described previously (Seah et al, 1971a 
CROHN 'S DISEASE
This was the only other disease in which the antireticulin antibody was found in a significant proportion of patients since it was present in nine (24 %) of the 38 patients. The antibody was only found at the lower titres, however, ie, 1 :10 in seven and 1 :20 in two. It was not present at 1:40 or 1: 80 in any of these patients.
OTHER DISORDERS
Of the 434 other sera tested, the antireticulin antibody was present in six (1-4%). It was found in two patients who were pregnant, in one patient with tropical sprue, in one patient with pernicious anaemia, in one patient with a reticulum cell sarcoma, and in one patient with vitiligo (table II) . It was only present at a titre above 1 :10 in the patient with reticulum cell sarcoma (titre 1:20) and in the patient with vitiligo (1: 80). 
Discussion
These results show that the antireticulin antibody occurs predominantly in three diseases: adult and childhood coeliac disease, dermatitis herpetiformis, and other skin, gastrointestinal and haematological disorders, which may have similar clinical presentations did not have the antibody present in their sera. The incidence of the antireticulin antibody in this study gives similar results to those previously reported, ie, approximatelya third of patients with adult coeliac disease (Seah et al, 1971a; Alp and Wright, 1971) , two-thirds of patients with childhood coeliac disease (Seah et al, 1971b; Alp and Wright, 1971 ; Von Essen, et al 1972) , a fifth of patients with dermatitis herpetiformis (Seah et al, 1971a) , and a quarter of patients with Crohn's disease (Alp and Wright, 1971) . In addition to the higher incidence of the antibody in childhood coeliac disease compared to adult coeliac disease and dermatitis herpetiformis there was a much higher incidence of the antibody at a higher titre in the childhood form of the disease. Children with coeliac disease more commonly respond to gluten withdrawal than adults and the particularly high incidence of the antibody in childhood coeliac disease may be related to this high incidence of gluten sensitivity. This is consistent with the finding of a definite relationship in coeliac disease and dermatitis herpetiformis between the presence of antireticulin antibody and whether or not the patients were taking gluten in the diet since all three groups-childhood coeliac disease, adult coeliac disease, and dermatitis herpetiformis-showed a significantly lower incidence of the antibody in the sera if the patients were taking a gluten-free diet.
At the present time, the exact significance of antireticulin antibody is uncertain and if it is due to cross reactivity between gluten and reticulin it is difficult to explain why the antibody is not present in the sera of all untreated patients who have dermatitis herpetiformis or coeliac disease, ie, all patients with gluten-sensitive enteropathy. It is possible, however, that all the antibody is bound to tissues in some patients and this could account for its absence from serum. Moreover, many of the patients classified as taking a normal diet had, in fact, received a glutenfree diet at some time previously and may still be taking relatively small amounts of gluten. On the other hand, the antibody in the sera of some patients receiving a gluten-free diet may arise because they are not strictly adhering to the diet.
We found no relation between the degree of histological abnormality of the small intestine in coeliac disease and dermatitis herpetiformis and the presence of antireticulin antibody. Von Essen et al (1972) did not detect antireticulin antibody in the sera of children with cow's milk intolerance, 10 of whom had been exposed to gluten, although the histological features of the small intestinal mucosa were similar to those seen in childhood coeliac disease. Moreover, these workers also found the antibody in four of 23 patients with IgA deficiency who showed normal jejunal mucosa. Further, as shown here, the antibody is absent from the sera of patients with the diffuse small intestinal mucosal damage of tropical sprue. Taken altogether, these findings, therefore, do not support the suggestion of Alp and Wright (1971) that the antireticulin antibody may be a non-specific result of dietary protein passing through a damaged small intestinal mucosa.
The finding of antireticulin antibody in approximately 25 % of patients with Crohn's disease is difficult to explain if the antibody is closely related to gluten sensitivity. None of the positive sera in the patients with Crohn's disease studied here, however, showed antibody titres as high as those found in some cases of untreated childhood coeliac disease, adult coeliac disease, and dermatitis herpetiformis. Whether the antibody present is identical in all these conditions and why it arises in both glutensensitive enteropathy and Crohn's disease remains obscure.
The finding of antireticulin antibody in six out of 434 patients with various disorders (two were pregnant, one had vitiligo, one pernicious anaemia, one tropical sprue, and one reticulum cell sarcoma) has to be explained. Subclinical coeliac disease is not rare and it is possible that these six patients have a gluten-sensitive enteropathy which has not been diagnosed but it was not possible to obtain jejunal biopsy material from any of them. Only one of the patients had the antibody present at a titre of 1: 80 and this was the patient with vitiligo. This patient was under weight and there was a family history of vitiligo suggesting autoimmune disease. Another possibility, and this, as mentioned above, may apply to patients with Crohn's disease, is that there is, in fact, a difference in the antireticulin antibody between patients who have gluten sensitivity and those who do not. Further work is in progress to investigate this theory.
Our findings do not support those of Alp and Wright who found the antireticulin antibody in ulcerative colitis and psoriasis. These authors also found the antibody in patients with uveitis, aphthous ulceration, and the irritable colon syndrome, and in as many as three (4 %) of 68 normal adults, whereas we have not detected the antibody in 60 normal adult subjects. The difference in these findings may arise because Alp and Wright tested their sera at a dilution of 1: 5 whereas the highest concentration we have used is 1:10.
At the present time it would appear that the presence of the antireticulin antibody and its titre, as demonstrated by indirect immunofluorescence, is a useful test in establishing the diagnosis of coeliac disease, dermatitis herpetiformis, and Crohn's disease. It would seem to be of particular help in the diagnosis of coeliac disease in children as there is a particularly high incidence of the antibody in this disease and because Crohn's disease is rare in children.
